Christa DeFries, MD

Dr. Maxim Chasanov, MD, brings over 30 years of experience in both inpatient and outpatient psychiatric settings. He has held leadership roles, including serving as Medical Director across various clinical programs. Dr. Chasanov completed his undergraduate studies at the University of Chicago and earned his medical degree from Loyola University Stritch School of Medicine in Chicago, Illinois. He completed his residency at Loyola University Medical Center, where he was appointed chief resident during his final year.

Dr. Chasanov values open, honest communication and takes a collaborative approach to care. He partners with patients to identify clear treatment goals and uses symptom screener tools to objectively track progress. He strives to create a warm, supportive, and empathetic environment where patients feel heard, respected, and actively engaged in their treatment journey.

In the first session, Dr. Chasanov works to gain a thorough understanding of each patient’s history, current concerns, and long-term goals. He then develops a personalized treatment plan aligned with those goals. His approach balances symptom improvement with medication tolerability and incorporates therapies that further enhance outcomes.

Dr Hannah Goddard is an adult psychiatrist who is originally from Northeast Ohio. She earned her undergraduate degree at Marquette University and completed her medical degree at Lake Erie College of Osteopathic Medicine in Erie, PA. Dr. Goddard completed her residency in psychiatry at MetroHealth Medical Center in Cleveland, Ohio, where she served as chief resident her final year.

Dr Goddard has experience treating a wide range of conditions including depression, anxiety, ADHD, and PTSD. The initial evaluation includes taking a comprehensive history and getting to know patients as individuals.

Her clinical philosophy centers on an empathetic, nonjudgmental, holistic approach. Dr Goddard collaborates closely with patients to develop a personalized treatment plan that integrates psychiatric medication management with supportive psychotherapy as well as elements of CBT.

‍

Dr. Patricia Michel-Garrison is a board-certified psychiatrist by the American Osteopathic Board of Neurology and Psychiatry (AOBNP) with over a decade of experience in inpatient psychiatry. She completed her undergraduate training in Chemistry in Florida, having moved there from Chicago in 2000, followed by medical school at the Lake Erie College of Osteopathic Medicine (LECOM). She completed her residency in Psychiatry in Largo, Florida. Dr. Michel-Garrison specializes in treating adults aged 18 and over, addressing a wide range of psychiatric conditions including anxiety, mood disorders, and personality disorders. She is known for her holistic approach, integrating both traditional and osteopathic principles to provide comprehensive care. Her treatment style is patient-centered, emphasizing individualized care plans tailored to each patient's unique needs. Dr. Michel-Garrison fosters a collaborative therapeutic relationship, promoting open communication and trust with her patients. Throughout her career, Dr. Michel-Garrison has remained committed to staying current with the latest advancements in psychiatric care. She is dedicated to helping her patients achieve optimal mental health and well-being through a combination of evidence-based practices and empathetic support.

Dr. Michelle Zaydlin is a board-certified psychiatrist who has experience in caring for diverse patient populations presenting with an array of diagnoses. Her interests include neurodevelopmental disorders (autism, ADHD), mood disorders, anxiety, trauma, and comorbid medical conditions. She has completed internships in pediatric neuropsychology and worked as a behavior therapist, delivering Applied Behavior Analysis (ABA) therapy, enriching her understanding of development and neurocognitive functioning. Additionally, Dr. Zaydlin actively participates in research and is actively engaged in educational initiatives for other healthcare providers. Dr. Zaydlin believes in a collaborative and compassionate approach to mental health care. She works with patients across their lifespans, integrating psychopharmacology and psychotherapy. She integrates cultural sensitivity with evidence-based practices to provide individualized, holistic care. Her empathetic approach and clinical knowledge enable her to foster meaningful connections with her patients and facilitate positive treatment outcomes.

Dr. Benjamin Adler is a physician who specializes in adult psychiatry. He utilizes medication management in conjunction with therapy. His practice includes the treatment of multiple mental health conditions including depression, anxiety, bipolar disorder, PTSD, ADHD, and OCD. Dr. Adler emphasizes a holistic approach to treatment that is non-judgemental and compassionate. He works closely with patients to establish plans that fit their individualized needs. Dr. Adler is a graduate of Johns Hopkins University, where he received his Bachelor of Science degree in Neuroscience. He attended medical school at Touro College of Osteopathic Medicine, graduating with honors. Dr. Adler completed his psychiatry residency at Woodmont Hospital in South Florida, where he supervised junior residents and medical students.

Dr. Amber Blue is a board-certified psychiatrist trained in Adult Psychiatry. She completed her residency at Yale University. She offers medication management in 30-minute follow-up visits informed by her psychotherapy experience. Occasionally, she may believe additional therapy would be beneficial, and therefore, she recommends that you add a therapist to your care team for the best results. She has received specialized training in psychoanalytic psychotherapy at Columbia University and NYU. Over the past three years, Dr. Blue has worked in college student health centers and private practice. She has a wide range of experience in treating various mental illnesses including depression, bipolar disorder, anxiety, and OCD. Her approach is to educate clients on their mental health, available pharmacologic and psychotherapeutic options, and to collaborate with them in formulating an evidence-based treatment plan.